'daunorubicin' can also refer to...



daunorubicin n.

daunorubicin n.

daunorubicin n.

daunorubicin n.

Daunorubicin efflux in Streptomyces peucetius modulates biosynthesis by feedback regulation

Aging Increases the Cardiotoxicity of Daunorubicin and Daunorubicinol in the Rat

Synthesis and binding properties of conjugates between oligodeoxynucleotides and daunorubicin derivatives

Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL

Administration Schedule of Daunorubicin for Elderly Patients with Acute Myelogenous Leukemia: A Single-institute Experience

Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma*

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment

Modulation of dnrN expression by intracellular levels of DnrO and daunorubicin in Streptomyces peucetius

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

The DrrC protein of Streptomyces peucetius, a UvrA-like protein, is a DNA-binding protein whose gene is induced by daunorubicin


More Like This

Show all results sharing this subject:

  • Medicine and Health


Show Summary Details

Quick Reference

n. an anthracycline antibiotic that interferes with DNA synthesis and is used in the treatment of acute leukaemias and AIDS-related Kaposi’s sarcoma. It is administered by intravenous infusion. Possible side-effects include loss of hair and damage to bone marrow and heart muscle. Trade name: DaunoXome.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.